Fundz

Liminatus Pharma reported raising $1.86 Million in an initial SEC Form D filing, from an offering of $1.86 Million

PUBLIC · LIMNJun 18, 2026

Amount Raised

$1.86 Million

$1.86 Million sold, per SEC Form D (first sale Jun 3, 2026)

Round Type

Venture

La PalmaBiotechnologyPharmaceutical

Quick answer

Liminatus Pharma raised $1.86 Million in a funding round, dated June 3, 2026. Liminatus Pharma is based in La Palma, California, United States.

How much did Liminatus Pharma raise?
Liminatus Pharma raised $1.86 Million in a funding round on June 3, 2026.
What does Liminatus Pharma do?
Liminatus Pharma, LLC is a private pharmaceutical company that is set to be integrated into Iris Acquisition Corp through a proposed business combination.
Where is Liminatus Pharma based and how big is it?
Liminatus Pharma is based in La Palma, California, United States. Fundz records about 3 employees.
Who are the decision-makers at Liminatus Pharma?
Fundz holds 1 contact at Liminatus Pharma, including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Biotechnology around the same time

Companies in the same sectors as Liminatus Pharma that raised within 45 days of this round, from Fundz verified event records.

  • GMP Manufacturing Ltd raised $667K (Debt Financing) on July 8, 2026.
  • Alchemab Therapeutics raised $33M (Series A) on July 8, 2026.
  • CurifyLabs raised $14M (Series A) on July 6, 2026.
  • Os Therapies raised $1.6M on June 30, 2026.
  • Autotelic Bio raised an undisclosed amount (Series B) on June 29, 2026.
  • Decoy Therapeutics raised $3.5M (Post-IPO Equity) on June 29, 2026.

Who to call at Liminatus Pharma, and when

A new round usually means Liminatus Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Liminatus Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Liminatus Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Liminatus Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Liminatus Pharma

Location

La Palma, California, United States

About

Liminatus Pharma, LLC is a private pharmaceutical company that is set to be integrated into Iris Acquisition Corp through a proposed business combination. The merger aims to bring Liminatus into the public market by becoming a part of Iris's corporate structure.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Liminatus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsChris K., Chief Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Liminatus Pharma's next move

See what Strategic adds

Liminatus Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.